Subscribe for email alerts

Don’t miss a single Science & Enterprise post. Sign up for our daily email alerts.

Donate to Science & Enterprise

Please share Science & Enterprise

Companies Partner on Implanted Diabetes Beta Cell Device

Diabetes blood glucose test

A company developing implants that release cell therapies is collaborating with a producer of regenerative stem cells to dispense insulin for people with diabetes. . . . → Read More: Companies Partner on Implanted Diabetes Beta Cell Device

Univ. Lab Licenses Protein for Vaccine Patch

Nanopatch system

A company developing a needle patch for vaccine delivery is acquiring the rights to a synthetic SARS-Cov-2 spike protein for its Covid-19 vaccine patch. . . . → Read More: Univ. Lab Licenses Protein for Vaccine Patch

Drug Discovery Biotech Inks Partnering Deal, Gains $175M

Gregory Verdine

A biotechnology company discovering protein therapies in fungi is collaborating with drug maker GlaxoSmithKline to find new small molecule drugs. . . . → Read More: Drug Discovery Biotech Inks Partnering Deal, Gains $175M

Synthetic Antibodies to be Designed with Organoids

Lymph node organoid

A biotechnology enterprise plans to discover synthetic antibodies with 3-D printed lymph node tissue for future licensing to a pharma company. . . . → Read More: Synthetic Antibodies to be Designed with Organoids

Patent Board Rules for Broad Inst. in Crispr Case

Crispr graphic

A U.S. patent appeals board ruled that the Broad Institute at Harvard and MIT is the discoverer of Crispr gene editing techniques in animal cells. . . . → Read More: Patent Board Rules for Broad Inst. in Crispr Case

Pharma Company Licenses Protein Delivery Hydrogel

Gel sample

A drug maker acquired commercialization rights to an injectable hydrogel developed at a university lab that delivers proteins to repair diseased tissue. . . . → Read More: Pharma Company Licenses Protein Delivery Hydrogel

University Lab Licenses Printed Kidney Tissue Process

Kidney organoid with capillary

A start-up company is acquiring the rights to a stem cell and three-dimensional printing process to produce tissue needed by people with kidney failure. . . . → Read More: University Lab Licenses Printed Kidney Tissue Process

Biotech Partners on Gene Editing Tech in $1.35B Deal

Gene therapy graphic

A biotechnology company is making its precise gene editing technology available to drug maker Pfizer for rare diseases, in a deal valued at $1.35 billion. . . . → Read More: Biotech Partners on Gene Editing Tech in $1.35B Deal

Patent Awarded for Opioid Risk System with Geographic Data

Networked earth

A company analyzing public health data by geography and social factors received a patent for its system identifying likely opioid addiction hot spots. . . . → Read More: Patent Awarded for Opioid Risk System with Geographic Data

Regeneron Gains Cancer, Infectious Disease Immunotherapies

Regeneron lab

A biotechnology company is licensing five of its vaccines for cancer and infectious diseases to Regeneron Pharmaceuticals in a deal valued at nearly $1 billion. . . . → Read More: Regeneron Gains Cancer, Infectious Disease Immunotherapies